ORTHOFIX International N V Stock – Fundamental Analysis

Price
9.25
10/14/2026
Oct 1996
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 9/30/2026)

Balance Sheet Total Assets 850,647,000.00 ROE 52.91 %
Balance Sheet Total Equity 450,037,000.00 ROA -10.84 %
Cashflow Capital Expenditures -35,000,000.00 P/FCF -221.61
Cashflow Free Cash Flow -1,653,000.00 – –
Cashflow Operating Cash Flow 33,347,000.00 P/CF 10.99
Income Earnings per Share (diluted) -2.33 Div. Yield –
Income Net Income -92,192,000.00 P/E -3.97
Income Shares Outstanding 39,602,300.00 P/B 0.81
Income Total Revenue 822,312,000.00 P/S 0.45

Ratios calculated on: 10/14/2026

Company Description

Orthofix International N.V. (Orthofix) is a diversified, global medical device company focused on developing and delivering repair and regenerative solutions to the spine and orthopedic markets. The Company operates in two global business units, which include Spine and Orthopedics. It designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for spine and orthopedic applications. Its main products are spinal implant products and related human cellular and tissue based products (HCT/P products) used in surgical procedures, non-invasive regenerative stimulation products used to enhance bone growth and the success rate of spinal fusions and to treat non-union fractures, external and internal fixation devices used in fracture repair, limb lengthening and bone reconstruction.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.orthofix.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more